5 factors for recurrence of bone cancer after surgery

Most bone cancers can achieve satisfactory results through active treatment, but the harm to the human body comes more from its recurrence and metastasis, so we must pay attention to prevention. The main reasons for the recurrence of bone cancer after surgery are as follows:

1. Not paying attention to consolidation treatment and follow-up

Some bone cancer patients think that everything is fine after undergoing surgical treatment and recovering, so they relax the subsequent consolidation treatment, stop taking medication on time, and do not follow the doctor's advice for regular follow-up examinations. They only regret it when bone cancer recurs.

2. Low immunity

Many bone cancer patients have already had reduced immunity before surgery, and the trauma of surgery and anesthesia have a blow to the body's resistance, which leads to even lower immunity. If you do not pay attention to strengthening nutrition and fail to restore immunity in time after surgery, it will provide opportunities for tumor recurrence or metastasis.

3. Bad Mood

Traditional Chinese medicine believes that many diseases are caused by internal injuries caused by the seven emotions. Frequent anger, depression, and irritability can easily lead to poor circulation of qi and blood in the body, organ dysfunction, and induce disease. For bone cancer patients, bad moods and excessive mental stress can also easily lead to recurrence.

4. Life is unpredictable

Traditional Chinese medicine believes that an important point in keeping healthy is to "go to bed early and get up early, and have a regular daily routine", which means that people should have a regular life, which is beneficial to health. Some bone cancer patients do not pay attention to daily details after recovery, often overeating, day and night reversal, excessive drinking, smoking, resulting in a decrease in the body's resistance, giving bone cancer an opportunity to recur.

5. Related to the patient's age

Affected by the level of cell metabolism, the malignancy of elderly bone cancer patients is relatively low and their prognosis is better, while the malignancy of young patients is relatively high, their prognosis is poor, and they are more likely to relapse.